Abhiraman G, Householder K, Rodriguez G, Glassman C, Saxton R, Breuer C
Nat Commun. 2025; 16(1):2432.
PMID: 40069219
PMC: 11897282.
DOI: 10.1038/s41467-025-57681-1.
Cousin A, Oger M, de Jenlis A, Lejart A, Barbier L, Riccobono D
Heliyon. 2025; 11(3):e42194.
PMID: 39995928
PMC: 11848091.
DOI: 10.1016/j.heliyon.2025.e42194.
Skinner K, Fisher T, Lee A, Su T, Forte E, Sanchez A
bioRxiv. 2025; .
PMID: 39975277
PMC: 11839055.
DOI: 10.1101/2025.02.07.637157.
Bick F, Blanchetot C, Lambrecht B, Schuijs M
MAbs. 2025; 17(1):2468312.
PMID: 39967341
PMC: 11845063.
DOI: 10.1080/19420862.2025.2468312.
Su L, Jia Y, Li Y, Shi J
Inflamm Res. 2025; 74(1):22.
PMID: 39862302
DOI: 10.1007/s00011-025-02001-y.
Diagnostics and Therapy for Malignant Tumors.
Tsai C, Wang C, Chang H, Chang P, Chang C, Chu T
Biomedicines. 2025; 12(12.
PMID: 39767566
PMC: 11726849.
DOI: 10.3390/biomedicines12122659.
design and structure of a peptide-centric TCR mimic binding module.
Householder K, Xiang X, Jude K, Deng A, Obenaus M, Wilson S
bioRxiv. 2025; .
PMID: 39763827
PMC: 11702606.
DOI: 10.1101/2024.12.16.628822.
Throw out an oligopeptide to catch a protein: Deep learning and natural language processing-screened tripeptide PSP promotes Osteolectin-mediated vascularized bone regeneration.
Chen Y, Chen L, Wu J, Xu X, Yang C, Zhang Y
Bioact Mater. 2024; 46:37-54.
PMID: 39734571
PMC: 11681832.
DOI: 10.1016/j.bioactmat.2024.11.011.
Leveraging Evolutionary Immunology in Interleukin-6 and Interleukin-17 Signaling for Lung Cancer Therapeutics.
Khilwani R, Singh S
ACS Pharmacol Transl Sci. 2024; 7(12):3658-3670.
PMID: 39698267
PMC: 11650734.
DOI: 10.1021/acsptsci.4c00412.
Engineering synthetic suppressor T cells that execute locally targeted immunoprotective programs.
Reddy N, Maachi H, Xiao Y, Simic M, Yu W, Tonai Y
Science. 2024; 386(6726):eadl4793.
PMID: 39636990
PMC: 11831968.
DOI: 10.1126/science.adl4793.
Durable antitumor response via an oncolytic virus encoding decoy-resistant IL-18.
Cheng Y, Zhao Y, Liu Y, Zhang Y, Xu D, Sun W
J Immunother Cancer. 2024; 12(12.
PMID: 39631848
PMC: 11624705.
DOI: 10.1136/jitc-2024-009716.
Thermal-responsive activation of engineered bacteria to trigger antitumor immunity post microwave ablation therapy.
Wu Y, Liu B, Yan Y, Gong C, Wang K, Liu N
Nat Commun. 2024; 15(1):10503.
PMID: 39627266
PMC: 11614905.
DOI: 10.1038/s41467-024-54883-x.
Crosstalk of pyroptosis and cytokine in the tumor microenvironment: from mechanisms to clinical implication.
Wang H, Wang T, Yan S, Tang J, Zhang Y, Wang L
Mol Cancer. 2024; 23(1):268.
PMID: 39614288
PMC: 11607834.
DOI: 10.1186/s12943-024-02183-9.
Role of long non-coding RNAs in neurofibromatosis and Schwannomatosis: pathogenesis and therapeutic potential.
Hussain M, Sharma S, Kumari A, Kamran A, Bahl G, Bisht A
Epigenomics. 2024; 16(23-24):1453-1464.
PMID: 39601046
PMC: 11622780.
DOI: 10.1080/17501911.2024.2430170.
Advances in the study of artemisinin and its derivatives for the treatment of rheumatic skeletal disorders, autoimmune inflammatory diseases, and autoimmune disorders: a comprehensive review.
Long Z, Xiang W, Xiao W, Min Y, Qu F, Zhang B
Front Immunol. 2024; 15:1432625.
PMID: 39524446
PMC: 11543433.
DOI: 10.3389/fimmu.2024.1432625.
"Dictionary of immune responses" reveals the critical role of monocytes and the core target IRF7 in intervertebral disc degeneration.
Xu P, Li K, Yuan J, Zhao J, Pan H, Pan C
Front Immunol. 2024; 15:1465126.
PMID: 39483476
PMC: 11524831.
DOI: 10.3389/fimmu.2024.1465126.
The Association between Gut Microbiota and Serum Biomarkers in Children with Atopic Dermatitis.
Kalashnikova I, Nekrasova A, Korobeynikova A, Bobrova M, Ashniev G, Bakoev S
Biomedicines. 2024; 12(10).
PMID: 39457662
PMC: 11505256.
DOI: 10.3390/biomedicines12102351.
Understanding bladder cancer risk: Mendelian randomization analysis of immune cell and inflammatory factor influence.
Un H, Wusimanjiang W, Zhan W, Zhang X, Li M, Lei J
Front Immunol. 2024; 15:1460275.
PMID: 39450166
PMC: 11499096.
DOI: 10.3389/fimmu.2024.1460275.
Application of novel CAR technologies to improve treatment of autoimmune disease.
Cheever A, Kang C, ONeill K, Weber K
Front Immunol. 2024; 15:1465191.
PMID: 39445021
PMC: 11496059.
DOI: 10.3389/fimmu.2024.1465191.
Future applications of host direct therapies for infectious disease treatment.
Thom R, DElia R
Front Immunol. 2024; 15:1436557.
PMID: 39411713
PMC: 11473292.
DOI: 10.3389/fimmu.2024.1436557.